nevirapine has been researched along with etonogestrel in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baum, MM; Kennedy, S; Malone, AM; Moss, JA; Motamedi, M; Nguyen, C; Smith, TJ; Vincent, KL | 1 |
| Ahluwalia, J; Ananworanich, J; Chaithongwongwatthana, S; Cremers, S; Kerr, S; Landolt, NK; Lange, JM; Phanuphak, N; Pinyakorn, S; Thammajaruk, N; Thomas, T; Thongpaeng, P; Ubolyam, S | 1 |
| Achilles, SL; Chappell, CA; Chen, BA; Cohn, SE; Darin, KM; Lamorde, M; Mackline, H; Nakalema, S; Riddler, SA; Scarsi, KK | 1 |
| Achilles, SL; Chappell, CA; Chen, BA; Lamorde, M; Matovu, J; Nakalema, S; Neary, M; Owen, A; Scarsi, KK; Siccardi, M | 1 |
| Baeten, JM; Blue, SW; Erikson, DW; Kelly, EJ; Kim, CJ; Kourtis, AP; Lingappa, JR; Mugo, N; Nanda, K; Patel, RC; Scarsi, KK; Stalter, RM; Tamraz, B; Thomas, KK | 1 |
1 review(s) available for nevirapine and etonogestrel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for nevirapine and etonogestrel
| Article | Year |
|---|---|
Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Desogestrel; Drug Interactions; Female; Genotype; HIV Infections; Humans; Nevirapine; Polymorphism, Single Nucleotide; Young Adult | 2019 |
4 other study(ies) available for nevirapine and etonogestrel
| Article | Year |
|---|---|
Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model.
Topics: Adenine; Administration, Intravaginal; Animals; Anti-Retroviral Agents; Biopsy; Contraceptive Agents; Desogestrel; Drug Evaluation, Preclinical; Estradiol; Female; Intrauterine Devices, Medicated; Models, Animal; Nevirapine; Organophosphonates; Saquinavir; Sexually Transmitted Diseases, Viral; Sheep; Tenofovir; Time Factors | 2013 |
Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; HIV Infections; Humans; Nevirapine; Prospective Studies | 2014 |
Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.
Topics: Adolescent; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Contraception; Contraceptive Agents, Female; Cyclopropanes; Desogestrel; Drug Antagonism; Female; HIV Infections; Humans; Middle Aged; Nevirapine; Uganda; Young Adult | 2017 |
A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Desogestrel; Drug Antagonism; Female; HIV Infections; Humans; Kenya; Levonorgestrel; Linear Models; Nevirapine; Pharmacogenomic Testing; Uganda | 2019 |